Illumina's stock surged 5.98% in pre-market trading on Friday, following multiple analyst upgrades and price target revisions.
Several financial institutions raised their price targets on Illumina, including Barclays (to $122 from $110), JP Morgan (to $125 from $120), Leerink Partners (to $175 from $160), JPMorgan (to $125 from $120), and Evercore ISI (to $155 from $150). Evercore ISI also maintained its Outperform rating on the shares.
These analyst actions reflect increased optimism about Illumina's future performance, driving the significant pre-market price appreciation.